United Services Automobile Association Iovance Biotherapeutics, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $330,836 - $478,140	-18,390 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $48,064 - $76,352	6,400 Added 53.38%	18,390 $163,000
Q3 2018 Nov 13, 2018	SELL	$11.25 - $17.7 $28,158 - $44,303	-2,503 Reduced 17.27%	11,990 $135,000
Q2 2018 Aug 10, 2018	BUY	$12.45 - $16.95 $42,715 - $58,155	3,431 Added 31.02%	14,493 $186,000
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $89,602 - $215,709	11,062 New	11,062 $187,000

342

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $562M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.